Croissance, taille, part, tendances, analyse des principaux acteurs et prévisions du marché des matrices extracellulaires jusqu’en 2028

  • Report Code : TIPRE00004925
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 160
Buy Now

Extracellular Matrix Market Size & Growth | Report, 2021-2028

Buy Now

 

Le marché des matrices extracellulaires devrait atteindre 52,72 millions de dollars US d’ici 2028, contre 31,49 millions de dollars US en 2021. Il devrait croître à un TCAC de 7,6 % de 2021 à 2028.

La matrice extracellulaire est présente sur la face externe des tissus et aide les tissus à lier les cellules avec du collagène. Il se compose de protéines structurelles, de glycoprotéines, de glycosaminoglycanes et de protéoglycanes. La matrice extracellulaire permet aux cellules réceptrices de repousser et est donc utilisée dans diverses applications, notamment dans les procédures de réparation cardiaque et vasculaire. Plusieurs facteurs, tels que l’incidence croissante des maladies cardiovasculaires et des traumatismes et l’augmentation des procédures de reconstruction vasculaire, stimulent la croissance du marché des matrices extracellulaires . Cependant, les défis liés à l’utilisation de la matrice extracellulaire décellulaire entravent la croissance du marché.

 

Personnalisez la recherche en fonction de vos besoins

Nous pouvons optimiser et adapter l’analyse et la portée qui ne sont pas satisfaites par nos offres standard. Cette flexibilité vous aidera à obtenir les informations exactes nécessaires à la planification de votre entreprise et à la prise de décision.

Marché des matrices extracellulaires : perspectives stratégiques

Marché des matrices extracellulaires
  • Extracellular Matrix Market
    TCAC (2021 - 2028)
    7,6%
  • Taille du marché 2021
    31,49 millions de dollars américains
  • Taille du marché 2028
    52,72 millions de dollars américains

Dynamique du marché

MOTEURS DE CROISSANCE
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
TENDANCES FUTURES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITÉS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Joueurs clés

  •  
  • Antéris
  • Aziyo Biologics, Inc.
  • Groupe Coloplast
  • Cook Biotech, Inc.
  • DSM Biomédical
  • Baxter
  • Medtronic
  • Merck KGaA
  • Produits biologiques MTF

Aperçu régional

Extracellular Matrix Market
  • Amérique du Nord
  • L'Europe 
  • Asie-Pacifique
  • Amérique du Sud et Centrale
  • Moyen-Orient et Afrique

Segmentation du marché

Extracellular Matrix MarketMatière première
  • Bovine
  • Porcin
  • Autre matière première
Extracellular Matrix MarketApplication
  • Réparation des tissus mous
  • Réparation Durale
  • Guérison des plaies
  • Réparation cardiaque
  • Réparation péricardique
  • Réparation et reconstruction vasculaire
  • L'exemple de PDF présente la structure du contenu et la nature des informations avec une analyse qualitative et quantitative.



 

Aperçus du marché

 

L’incidence croissante des troubles cardiovasculaires et des traumatismes stimule la croissance du marché des matrices extracellulaires

L’augmentation significative des cas de traumatismes orthopédiques et de maladies cardiovasculaires est le principal facteur de croissance du marché mondial des matrices extracellulaires. Dans le cadre du traitement, la matrice extracellulaire offre plusieurs avantages dans le traitement de différentes blessures chroniques causées par des interventions chirurgicales, des accidents, des maladies chroniques et d'autres incidents. De plus, les incidences d’insuffisance cardiaque et d’infarctus du myocarde augmentent parmi la population vieillissante. Le traitement mini-invasif de ces procédures de traitements cardiovasculaires nécessite une matrice extracellulaire. Un patient souffrant d'une maladie cardiaque ne parvient pas à restaurer les propriétés fonctionnelles du tissu cardiaque. La capacité de la matrice extracellulaire à repousser et à favoriser la réparation et la régénération adaptatives permet aux patients de retrouver leurs fonctions normales. En outre, il a montré des résultats cliniques prometteurs pour l’ingénierie tissulaire dans le traitement des maladies cardiovasculaires et d’autres problèmes de santé.

En outre, l’incidence croissante des maladies cardiovasculaires devrait stimuler la croissance de la matrice extracellulaire. Par exemple, selon les données de l’OMS publiées en 2019, on estime que 17,9 millions de personnes sont mortes de maladies cardiovasculaires en 2019, ce qui représente 32 % de tous les décès dans le monde. Parmi ces décès, 85 % étaient dus à une crise cardiaque ou à un accident vasculaire cérébral. Selon le rapport European Cardiovascular Disease Statistics de 2017, en Europe, chaque année, les maladies cardiovasculaires (MCV) provoquent 3,9 millions de décès et plus de 1,8 million de décès dans l'Union européenne (UE).

 

Informations basées sur les matières premières

Sur la base de la matière première, le marché des matrices extracellulaires est segmenté en matières premières bovines, porcines et autres. Le segment porcin devrait détenir la plus grande part du marché, tandis que le segment bovin devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.

Sur la base de l’application, le marché de la matrice extracellulaire a été segmenté en réparation des tissus mous,  réparation durale , cicatrisation des plaies, réparation cardiaque, réparation péricardique et réparation et reconstruction vasculaire. Le segment de la réparation des tissus mous devrait représenter une part de marché plus importante en 2021. Cependant, le segment de la réparation et de la reconstruction vasculaire devrait enregistrer un TCAC plus élevé sur le marché au cours de la période de prévision.

Diverses entreprises opérant sur le marché des matrices extracellulaires adoptent des stratégies de marketing, telles que des lancements de produits, des fusions et acquisitions, des collaborations, des innovations de produits et des expansions de portefeuille de produits pour étendre leur empreinte dans le monde entier, maintenir la marque et répondre à la demande croissante des utilisateurs finaux. .

 

Portée du rapport sur le marché des matrices extracellulaires

Attribut de rapportDétails
Taille du marché en 202131,49 millions de dollars américains
Taille du marché d’ici 202852,72 millions de dollars américains
TCAC mondial (2021 - 2028)7,6%
Données historiques2019-2020
Période de prévision2022-2028
Segments couvertsPar matière première
  • Bovine
  • Porcin
  • Autre matière première
Par candidature
  • Réparation des tissus mous
  • Réparation Durale
  • Guérison des plaies
  • Réparation cardiaque
  • Réparation péricardique
  • Réparation et reconstruction vasculaire
Régions et pays couvertsAmérique du Nord
  • NOUS
  • Canada
  • Mexique
L'Europe 
  • ROYAUME-UNI
  • Allemagne
  • France
  • Russie
  • Italie
  • Le reste de l'Europe
Asie-Pacifique
  • Chine
  • Inde
  • Japon
  • Australie
  • Reste de l'Asie-Pacifique
Amérique du Sud et Centrale
  • Brésil
  • Argentine
  • Reste de l'Amérique du Sud et centrale
Moyen-Orient et Afrique
  • Afrique du Sud
  • Arabie Saoudite
  • Émirats arabes unis
  • Reste du Moyen-Orient et Afrique
Leaders du marché et profils d’entreprises clés
  •  
  • Antéris
  • Aziyo Biologics, Inc.
  • Groupe Coloplast
  • Cook Biotech, Inc.
  • DSM Biomédical
  • Baxter
  • Medtronic
  • Merck KGaA
  • Produits biologiques MTF
  • L'exemple de PDF présente la structure du contenu et la nature des informations avec une analyse qualitative et quantitative.

 

 

Profils d'entreprise

  •  Antéris
  • Aziyo Biologics, Inc.
  • Groupe Coloplast
  • Cook Biotech, Inc.
  • DSM Biomédical
  • Baxter
  • Medtronic
  • Merck KGaA
  • Produits biologiques MTF
  • Smith et neveu
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of sleep apnea diagnostics?

Global extracellular matrix market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the rising prevalence of wounds and injuries. The growth of the market is mainly driven by the significant rise in cardiovascular disorders among the American population. And, Asia Pacific is the fastest-growing region growing at the CAGR of 8.2% during the forecast period.

Who are the key players in the extracellular matrix market?

The extracellular matrix market majorly consists of the players such as Anteris, Aziyo Biologics, Inc., Coloplast Group, Cook Biotech, Inc., DSM Biomedical, Baxter International, Inc., Medtronic, Merck KGaA, MTF Biologics, and Smith & Nephew, among others

Which application held the largest share in the extracellular matrix market?

The soft tissue repair segment dominated the global extracellular matrix market and accounted for the largest revenue share of 24.11% in 2021.

Which Raw Material led the extracellular matrix market?

The Porcine segment dominated the global extracellular matrix market and held the largest revenue share of 43.76% in 2021.

What is Extracellular Matrix?

Extracellular matrix is present in the outer side of the tissues and it helps tissues to bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans and proteoglycans. Extracellular matrix enables recipient cells to regrow and thus it is used in various applications which include cardiac and vascular repair procedure.

What are the driving factors for the extracellular matrix market across the globe?

Key factors that are driving the growth of this market are rising incidence of cardiovascular diseases and trauma along with increase in vascular reconstruction procedures.

The List of Companies - Extracellular Matrix Market

  1. Anteris
  2. Aziyo Biologics, Inc
  3. Coloplast Group
  4. Cook Biotech, Inc
  5. DSM Biomedical
  6. Baxter
  7. Medtronic
  8. Merck KGaA
  9. MTF Biologics
  10. Smith & Nephew

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..